Read More Pharma Industry News FDA approves Italfarmaco’s Duvyzat for duchenne muscular dystrophy treatment In a significant advancement for the treatment of Duchenne muscular dystrophy (DMD), Italfarmaco S.p.A. has announced the U.S.… byPallavi MadhirajuMarch 24, 2024